Paneez Khoury
Internal Medicine · Bethesda, MDNPI 1720203920
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $844 of the $1,160 with a category attached, or 72.8%. Every reported general payment came from a single manufacturer, Astrazeneca UK Limited.
Across 11 payments — averaging $105.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$1K
Across 7 payments — averaging $89,454 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$625K
- Regeneron$1K
What the payments were for
- Travel & lodging$84473%
- Food & beverage$31527%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 11 | $1,160 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$759
How this compares
$1,160 in reported general payments places this provider in the 75th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Bethesda
- Matthew MintzBethesda$135K
- Micaela IantornoBethesda$26K
- Marianne MannHighland$2.1M
- Param DedhiaBaltimore$636K
- Curtis RosebraughAshton$418K
- Mark CorriereColumbia$402K
- Gregory PokrywkaTowson$377K
- Shawn DhillonBaltimore$227K
- Brian HarveyAnnapolis$220K
- Jeremy SugarmanBaltimore$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.